Boston Scientific Corporation has agreed to acquire Baylis Medical Company Inc. for an upfront cash payment of $1.75 billion. The transaction, announced Oct. 6, is expected to close in early 2022. Baylis was represented by BCF Business Law and a Cooley team including partners Michal Berkner, William Corcoran, Joshua Friedman, Jacqueline Grise and Michael McGrail. Boston Scientific was advised by a Shearman & Sterling team led by partners Clare O’Brien and Derrick Lott.
October 06, 2021, 12:45 PM